Heart failure and CHF are some of the most costly chronic conditions to treat due to the severity and progression of the disease. A review published in the American Journal of Medicine estimates that the annual cost of treating heart failure among Medicaid beneficiaries ranges from $29,271 to $51,937. Despite advances in cardiovascular disease management, improvements in the mortality rates of heart failure patients has lagged behind other chronic conditions. In order to address the burden that heart failure poses, next-generation solutions are essential.
Technological advances in neurostimulation products are helping more people regain control of their lives from debilitating neurological disorders. Growth in the multibillion dollar neurostimulation market is showing no signs of slowing down as these devices become more accessible to the millions of people affected by neurological disorders. Significant fundraising and investment in the R&D of novel neurostimulation technologies lends additional evidence to the massive growth that this market is capable of in the future. A severely underserved population of patients with a myriad of difficult to treat disorders means there is an urgent need for novel solutions that provide therapeutic relief for chronic neurological conditions.
For start-ups to large corporations, the development and manufacturing of medical technologies has become a lucrative target, and one with the added benefit of improving the lives of people around the world.
The Emerging Medtech Summit 2020 will spotlight Sixty (60) of the hottest emerging medtech companies, many of which are raising capital, ripe for M&A, or already planning for an IPO or exit.
Life Science Intelligence (LSI) is a medical device market intelligence firm with deep roots and a long history covering various medtech and broader lifescience markets. This blog will be a place where LSI will share relevant company and industry updates of key interest to its customers: medical device manufacturers, emerging medtech startups, medtech focused investors, and like-minded service companies.